Project: Ghana Emergency Medicine Collaborative Document Title: Acute Congestive Heart Failure Author(s): Rashmi U. Kothari (Michigan State University), MD 2012 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Share Alike-3.0 License: http://creativecommons.org/licenses/by-sa/3.0/ We have reviewed this material in accordance with U.S. Copyright Law and have tried to maximize your ability to use, share, and adapt it. These lectures have been modified in the process of making a publicly shareable version. The citation key on the following slide provides information about how you may share and adapt this material. Copyright holders of content included in this material should contact open.michigan@umich.edu with any questions, corrections, or clarification regarding the use of content. For more information about how to cite these materials visit http://open.umich.edu/privacy-and-terms-use. Any medical information in this material is intended to inform and educate and is not a tool for self-diagnosis or a replacement for medical evaluation, advice, diagnosis or treatment by a healthcare professional. Please speak to your physician if you have questions about your medical condition. Viewer discretion is advised: Some medical content is graphic and may not be suitable for all viewers. 1
Attribution Key Use + Share + Adapt Make Your Own Assessment for more information see: http://open.umich.edu/wiki/attributionpolicy { Content the copyright holder, author, or law permits you to use, share and adapt. } Public Domain Government: Works that are produced by the U.S. Government. (17 USC 105) Public Domain Expired: Works that are no longer protected due to an expired copyright term. Public Domain Self Dedicated: Works that a copyright holder has dedicated to the public domain. Creative Commons Zero Waiver Creative Commons Attribution License Creative Commons Attribution Share Alike License Creative Commons Attribution Noncommercial License Creative Commons Attribution Noncommercial Share Alike License GNU Free Documentation License { Content Open.Michigan believes can be used, shared, and adapted because it is ineligible for copyright. } Public Domain Ineligible: Works that are ineligible for copyright protection in the U.S. (17 USC 102(b)) *laws in your jurisdiction may differ { Content Open.Michigan has used under a Fair Use determination. } Fair Use: Use of works that is determined to be Fair consistent with the U.S. Copyright Act. (17 USC 107) *laws in your jurisdiction may differ Our determination DOES NOT mean that all uses of this 3rd-party content are Fair Uses and we DO NOT guarantee that your use of the content is Fair. To use this content you should do your own independent analysis to determine whether or not your use will be Fair. 2
68 y.o. Female with Severe Shortness of Breath P=130 RR=32 BP=220/120 P.Oxm=86%è 90% DifferenEal Diagnosis PE CHF/Pulmonary edema Pneumonia COPD Pneumothorax Pericardial effusion 3
68 y.o. Female with Severe Shortness of Breath History Onset (gradual or sudden) Cough, fever, unilateral leg swelling Orthopnea, PND, DOE, Swelling PMH: CAD, CHF, PE/DVT, ESRD Same it past? 4
68 y.o. Female with Severe Shortness Physical Exam of Breath VS: (T/RR/HR/BP/Pulse Oxm) Neck: JVD Chest: ê BS, rales, wheezing, rhonchi Heart: Afib, bradycardia, distant HS, S3 ExtremiEes: edema, unilateral swelling, cord, tenderness 5
68 y.o. Female with Severe Shortness of Breath HPI: 3-4 days, cough, é é worse this am PMH: COPD, CHF, CAD, & HTN PE: Obese, severe resp. distress T=36.6 P=130 RR=32 BP=220/120 NRB=89-91% Chest: ê BS,?rales,?wheezing Cardiac: RRR no Murmur ExtremiEes: 2+ bilateral edema 6
Goal Review pathophysiology Evaluate diagnosec findings H&P, CXR, BNP, U/S Evaluate medical management Oxygen delivery, nitroglycerin, lasix, morphine 7
Acute CongesEve Heart Failure DefiniEon (CHF) 8
Diagnosis History & Physical Exam Chest X- ray Laboratory tests Ultrasound 9
Diagnosing CHF Increased Likelihood Decreased Likelihood Hx CHF LR=5.8 PND LR=2.6 S3 LR=11 + CXR LR=12 Afib LR=3.8 No hx CHF LR=.45 No DOE LR=.48 No rales LR=.51 - Cardiomegaly LR=.51 EKG WNL LR=.64 Wang et al. JAMA 2005 10
Wapcaplet, Wikimedia Commons Myocardial stretch/stress Pro- BNP A. Mukkamala NT- pro- BNP BNP A. Mukkamala 11 BotanyBRA, Wikimedia Commons
BNP and NT pro- BNP BNP NT pro- BNP AGE All <50 50-70 >70 Rule out <100 <300 <300 <1200 Sens/Spec 90%/74% 99%/85% 99%/85% 97%/55% Rule in >400 >450 >900 >4500 Sens/Spec 81%/90% 93%/95% 91%/80% 64%/86% References: Korenstein BM Emerg Med 2007 Jannuzi et al Am J Card 2005 Berdague et al., Am Heart J 12
Impact of High & Low BNP on Pre- Test ProbabiliEes Pre- test Probability Post- test Probability for BNP<105 pg/ml Post- test Probability for BNP >300 pg/ml 10% 2% 46% 30% 5% 77% 50% 12% 88% 70% 25% 95% 90% 56% 99% Reference: Korenstein Et. al.,bm Emerg Med 2007 13
Causes of Elevated BNP Acute CHF Renal Failure Sepsis Pulmonary Embolism 14
BNP Decreases LOS & Cost 6.3 hrs $6,129 5.8 hrs P=0.031 Reference: Mueller et.al., NEJM P=0.023 Reference: Moe et. al., Circ 2007 15
Summary of BNP Combining clinical judgment & BNP may improve accuracy of diagnosis Most helpful when diagnosis unclear (e.g. COPD) Can be elevated in ARF, sepsis or PE 16
Diagnosing CHF by Ultrasound Extravascular lung fluid Look for comet tails Elevated Rt heart filling pressures Examine IVC within 2 cm of Rt atrium 17
Ultrasound B- lines (Lung Rockets) in CHF Pros: Easy windows 80-90% sensievity & specificity Cons: Takes 2-5 minutes Limited data from ED 18
Lung Ultrasound for B- Lines (Lung Rockets) Use a 3-5 MHz Probe PosiEon 1: anterior chest view PosiEon 2: lateral chest views Drickey, Wikimedia Commons 19
Measuring IVC by Ultrasound in AHF Pros: Rapid 69%PPV & 91% NPV Accuracy 83% for é Atrial Pressures Cons: CorrelaEon é Atrial Pressures to AHF Technically challenging Reference: Blair JE, et al: Am J Card 2009 20
Management of Acute CHF Oxygen DiureEcs Nitroglycerin Morphine 21
CPAP/BiPAP Decreases Mortality & IntubaEon 25% 20% 15% 10% 5% 0% 45% mortality* 0.2 0.11 NIPVV Standard 35% 30% 25% 20% 15% 10% 5% 0% 42% IntubaCon* 0.31 0.18 NIPVV Standard *p<0.001 Reference: Masip et al. JAMA 2005 Reference: Masip et al. JAMA 2006 22
CPAP & BiPAP Equivalent CPAP = Bipap Mortality IntubaEon rates AMI Mortality CPAP BiPAP 6% 7% Reference: Masip et al. JAMA 2005 23
ED Study of NIPPV vs. Standard Medical Care (SMC) 1069 ED Randomized for 2 hrs of treatment CPAP BiPAP Oxygen by NC or FM Gray et al. NEJM 2008 24
No Difference NIPPV vs. SMC No Difference Mortality IntubaEon rates 12% 10% 8% 0.095 0.098 NIPPV Standard NIPPV beser 6% ê Respiratory distress ê Metabolic disturbances 4% 2% 0% 0.029 0.028 Moratlity IntubaEon Reference: Gray et al. NEJM 2008 25
Why Discrepancy Between Studies? Study Mortality IntubaCon Rate Gray et al. NEJM 16.5%??? 2.8% Masip et al JAMA 20% 31% Cochrane 20% 30% 26
Reason for Discrepancy Change in Treatment Standard Oxygen (N=367) IntubaEon 3 CPAP 43 NIPPV 13 Standard treatment Type treatment not noted 6 - - - 65/367 (18%) PaCents Crossed Over in Standard Treatment Group 27
Summary of NIPPV Most likely: Decreases mortality Decreases intubaeon rate Decreases respiratory distress Use in PaEents with: Significant respiratory distress O 2 SaturaEon <90% 28
68 y.o. Female in Severe CHF. Home Meds 80 mg Lasix How much IV Lasix should you give her? None 40 mg 80 mg 160 mg 29
Decreased EffecEveness of Loop DiureEcs in CHF Delayed onset of aceon 15-30 minutes normal paeents 45-120 minutes in CHF Drug resistance in chronic users 30
Cardiac Effects of Lasix Venous dilataeon Healthy subjects Maximized @ 20 mg Physiological Effect PVR é SVR é MAP é Arterial constriceon CHF paeents Predominates early HR RtAFP SV?? Catecholamines é é ê é 31
Worsening CreaEnine and Acute CongesEve Heart Failure Occurs in 72% of paeents with CHF Increased mortality é LOS 32
Increased Mortality Associated with Worsening CreaEnine RelaCve Risk of Death 3 2.5 2 1.5 1 0.5 0 2.9 1.91 1.67 1.19 0.89 >0.1 >0.2 >0.3 >0.4 >0.5 CreaCnine ElevaCon Reference: GoJlieb et al. J Card Fail 2002 33